Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic and Metagenomic Effects of Repopulation of the Intestinal Microbiome in Patients with Severe Unexplained Atherosclerosis

NCT04410003 is registered in ClinicalTrials.gov with Western University, Canada as lead sponsor.

NCT NCT04410003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04410003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic and Metagenomic Effects of Repopulation of the Intestinal Microbiome in Patients with Severe Unexplained Atherosclerosis
Lead sponsor
Western University, Canada
Phase
Phase 1
Overall status
Recruiting
Start date
June 2, 2020
Completion date
July 30, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, intestinal microbiome